Previous in vitro and in vivo results showed that the reduction of CXCL8 and CCL2 secretion inhibits some of the pro-tumorigenic effects mediated by both these chemokines in thyroid cancer (32). The gene discussed is CCL2; the disease is thyroid gland carcinoma.